NEXTCURE, INC Public Float
NEXTCURE, INC (NXTC) had Public Float of $12.60 million as of 2025-06-30, per its 10-K filed 2026-03-05.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-05
- 2025-06-30: Entity Public Float $12.60M.
- 2024-06-28: Entity Public Float $43.60M.
- 2023-06-30: Entity Public Float $49.20M.
- 2022-06-30: Entity Public Float $115.50M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $12.60M 10-K · filed 2026-03-05 |
| 2024-06-28 | $43.60M 10-K · filed 2025-03-06 |
| 2023-06-30 | $49.20M 10-K · filed 2024-03-21 |
| 2022-06-30 | $115.50M 10-K · filed 2023-03-02 |
| 2021-06-30 | $209.00M 10-K · filed 2022-03-03 |
| 2020-06-30 | $590.00M 10-K · filed 2021-03-04 |
| 2019-06-28 | $236.40M 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |